Status:
COMPLETED
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
Lead Sponsor:
Alejandro Krolewiecki
Collaborating Sponsors:
Brock University
Universidad Nacional del Centro de la Provincia de Buenos Aires
Conditions:
Trichuris Infection
Helminthiasis
Eligibility:
All Genders
2-14 years
Phase:
PHASE2
Brief Summary
There are four species of intestinal worms collectively known as soil-transmitted helminthiasis (STH): Ancylostoma duodenale and Necator americanus (hookworms), Ascaris lumbricoides (roundworms), and ...
Eligibility Criteria
Inclusion
- Infection with T. trichiura by Kato Katz.
- Body weight \>15kg.
- Accepts participation
Exclusion
- Albendazole and/or mebendazol treatment in the previous 3 months.
- Allergy to the study drugs
- Acute medical conditions
- Clinical trial participation in the previous 3 months.
- Pregnancy.
Key Trial Info
Start Date :
October 9 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2020
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04041453
Start Date
October 9 2019
End Date
March 7 2020
Last Update
July 29 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IIET
Orán, Salta Province, Argentina, 4530
2
Universidad Autónoma de Honduras
Tegucigalpa, Honduras